Autoimmune prematur ovarian insuffience

Clinical trials for Autoimmune prematur ovarian insuffience explained in plain language.

Never miss a new study

Get alerted when new Autoimmune prematur ovarian insuffience trials appear

Sign up with your email to follow new studies for Autoimmune prematur ovarian insuffience, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for fertility: drug may reverse early menopause in autoimmune patients

Disease control Recruiting now

This study tests whether an immunomodulatory drug (rituximab) can improve or normalize ovarian function in women aged 18-38 with autoimmune premature ovarian insufficiency (POI). Participants receive either rituximab or a placebo, and those who respond may undergo IVF. The goal i…

Matched conditions: AUTOIMMUNE PREMATUR OVARIAN INSUFFIENCE

Phase 3 • Sponsor: Angelica Lindén Hirschberg • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

Autoimmune prematur ovarian insuffience

Get alerted when new Autoimmune prematur ovarian insuffience trials appear

New hope for fertility: drug may reverse early menopause in autoimmune patients